HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brown, M. A. Articles by Bergmann, S. R. Search for Related Content PubMed PubMed Citation Articles by Brown, M. A. Articles by Bergmann, S. R.

Validity of Estimates of Myocardial Oxidative Metabolism with Carbon-11 Acetate and Positron Emission Tomography Despite Altered Patterns of Substrate Utilization

Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri

Correspondence: For reprints contact: Steven R. Bergmann, MD, PhD, Cardiovascular Division, Washington University School of Medicine, Box 8086, 660 South Euclid, St. Louis, MO 63110.

ABSTRACT

We recently demonstrated that the myocardial turnover rate constant (k) measured noninvasively with positron emission tomography (PET) after intravenous administration of [¹¹C]acetate provides a reliable index of myocardial oxidative metabolism (MVO₂) theoretically independent of the pattern of myocardial substrate use. However, because estimates of metabolism with other metabolic tracers are sensitive to substrate use, we measured k in 12 dogs during baseline conditions and again after infusion of either glucose (n = 8) or intralipid (n = 4), interventions that raised arterial glucose or fatty acids by more than fivefold with concomitant changes in myocardial substrate use. Following glucose administration k increased, but no difference was detected after compensation for changes in hemodynamics and myocardial work induced by the infusion (0.18 ± 0.03 min^–1 (t = 3.9 min) at baseline compared with 0.22 ± 0.06 min^–1 (t = 3.2 min, p = N.S.). k was not affected by intralipid infusion (k = 0.15 ± 0.06 min^–1 at baseline and 0.14 ± 0.04 min^–1 during infusion), and correlated closely with MVO₂ measured directly (n = 19 comparisons, r = 0.89). The results indicate that estimates of MVO₂ using [¹¹C]acetate and PET are valid despite changes in the pattern of myocardial substrate utilization.

This article has been cited by other articles:

				L. Juillard, S. Lemoine, M. F. Janier, P. Y. Barthez, F. Bonnefoi, and M. Laville Validation of Renal Oxidative Metabolism Measurement by Positron-Emission Tomography Hypertension, July 1, 2007; 50(1): 242 - 247. [Abstract] [Full Text] [PDF]

				P. F. Soto, P. Herrero, A. M. Kates, C. S. Dence, A. A. Ehsani, V. Davila-Roman, K. B. Schechtman, and R. J. Gropler Impact of aging on myocardial metabolic response to dobutamine Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2158 - H2164. [Abstract] [Full Text] [PDF]

				V.i. G. Davila-Roman, G. Vedala, P. Herrero, L. de las Fuentes, J. G. Rogers, D. P. Kelly, and R. J. Gropler Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy J. Am. Coll. Cardiol., July 17, 2002; 40(2): 271 - 277. [Abstract] [Full Text] [PDF]

				N. Ohte, K. Kurokawa, A. Iida, H. Narita, S. Akita, K. Yajima, H. Miyabe, J. Hayano, and G. Kimura Myocardial Oxidative Metabolism in Remote Normal Regions in the Left Ventricles with Remodeling After Myocardial Infarction: Effect of {beta}-Adrenoceptor Blockers J. Nucl. Med., June 1, 2002; 43(6): 780 - 785. [Abstract] [Full Text] [PDF]

				J. van den Hoff, W. Burchert, A.-R. Borner, H. Fricke, G. Kuhnel, G. J. Meyer, D. Otto, E. Weckesser, H.-G. Wolpers, and W. H. Knapp [1-11C]Acetate as a Quantitative Perfusion Tracer in Myocardial PET J. Nucl. Med., August 1, 2001; 42(8): 1174 - 1182. [Abstract] [Full Text] [PDF]

				A. F. Maes, F. Van de Werf, L. V. Mesotten, P. B. Flamen, R. S. Kuzo, J. L. Nuyts, and L. Mortelmans Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate J. Am. Coll. Cardiol., January 1, 2001; 37(1): 30 - 36. [Abstract] [Full Text] [PDF]

				K. J. Zehr, C. Y. Wong, B. Chin, H. T. Ravert, R. F. Dannals, R. H. Hruban, D. F. Wong, and W. A. Baumgartner Comparison of myocardial oxygen consumption using 11C acetate positron emission tomography scanning in a working and non-working heart transplant model Eur. J. Cardiothorac. Surg., January 1, 2001; 19(1): 74 - 81. [Abstract] [Full Text] [PDF]

				R. R. Sciacca, O. Akinboboye, R. Ling Chou, S. Epstein, and S. R. Bergmann Measurement of Myocardial Blood Flow with PET Using 1-11C-Acetate J. Nucl. Med., January 1, 2001; 42(1): 63 - 70. [Abstract] [Full Text] [PDF]

				T. Hata, R. Nohara, M. Fujita, R. Hosokawa, L. Lee, T. Kudo, E. Tadamura, N. Tamaki, J. Konishi, and S. Sasayama Noninvasive Assessment of Myocardial Viability by Positron Emission Tomography With 11C Acetate in Patients With Old Myocardial Infarction: Usefulness of Low-Dose Dobutamine Infusion Circulation, October 15, 1996; 94(8): 1834 - 1841. [Abstract] [Full Text]

				H. Iida, C. G. Rhodes, L. I. Araujo, Y. Yamamoto, R. de Silva, A. Maseri, and T. Jones Noninvasive Quantification of Regional Myocardial Metabolic Rate for Oxygen by Use of 15O2 Inhalation and Positron Emission Tomography: Theory, Error Analysis, and Application in Humans Circulation, August 15, 1996; 94(4): 792 - 807. [Abstract] [Full Text]

				V. H. D. Bruyn, S. R. Bergmann, B. A. Keyt, and B. E. Sobel Visualization of Thrombi in Pulmonary Arteries With Radiolabeled, Enzymatically Inactivated Tissue-Type Plasminogen Activator Circulation, September 1, 1995; 92(5): 1320 - 1325. [Abstract] [Full Text]